drugset / Trial / NCT01375452

Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting Conditions

NCT01375452

Phase 1 Completed 36 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare bioavailability in healthy, post menopausal women subjects under fasting conditions.

Timeline

Start
2008-03
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 2.5 mg Oral

Indications

No indication recorded.